Clinical Trials Directory

Trials / Completed

CompletedNCT01058070

An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Torax Medical Incorporated · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)

Detailed description

The purpose of this feasibility study is to collect preliminary performance and safety information and develop procedural optimization for the Torax Medical Inc. Magnetic Esophageal Sphincter device (MES) in reinforcement of Esophageal Sphincter function to treat Gastroesophageal Reflux Disease (GERD). The information from this study will be used to support the design and conduct of an expanded clinical trial.

Conditions

Interventions

TypeNameDescription
DEVICETorax Medical, Inc. LINX Reflux Management SystemImplantable device, Magnetic Esophageal Sphincter

Timeline

Start date
2007-02-01
Primary completion
2009-07-01
Completion
2013-08-01
First posted
2010-01-28
Last updated
2021-02-01
Results posted
2014-06-02

Locations

5 sites across 3 countries: United States, Italy, Netherlands

Source: ClinicalTrials.gov record NCT01058070. Inclusion in this directory is not an endorsement.